← Eichor
Condition: Lung Transplant Infection Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Lung Transplant Infection

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Clinical Study Evaluating the Pharmacokinetic Characteristics and Safety of AHB-137 Injection in Participants With Mil
Phase 1 · 5 location(s) · Ausper Biopharma Co., Ltd. · NCT07600788High vs. Standard Dose Influenza Vaccine in Lung Allograft Recipients
Phase 2 · 1 location(s) · Vanderbilt University Medical Center · NCT05215327Balloon Sinuplasty Efficiency in Maxillary Rhinosinusitis.
NA · 1 location(s) · Tampere University Hospital · NCT04645511Quantiferon CMV to Identify Treatment Need for Asymptomatic CMV Infection After Solid Organ Transplant (QUANTIFOT)
NA · 1 location(s) · University Hospital, Grenoble · NCT06341543Liquid biopsiEs fOr luNg AllogRaft Damage classificatiOn - LEONARDO
Phase N/A · 1 location(s) · Jesper Magnusson · NCT06679257Open Label Trial of Oral Letermovir for CMV Prophylaxis in Thoracic Transplant Recipients
Phase 2 · 1 location(s) · University of Pennsylvania · NCT06066957Prospective Multicenter Research on Donor and Recipient Management Strategies to Improve Lung Transplant Outcomes
Phase N/A · 19 location(s) · Duke University · NCT06399302A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
Phase 2 · 26 location(s) · Deciphera Pharmaceuticals, LLC · NCT06619561HALP Score, Blood-Based Inflammatory Indices, and Salivary MMP-8 in Periodontal Disease and Healing After Non-Surgical T
Phase N/A · 1 location(s) · Ömer Faruk Okumuş · NCT07312045Combination Letermovir and Standard of Care Antiviral for Enhanced Antiviral Response in Cytomegalovirus Infection in Lu
Phase 4 · 1 location(s) · University Health Network, Toronto · NCT07235683Real-world Study Evaluating the Long-term Outcomes of Pegylated Interferon α-2b Treatment in the Families With Clusters
Phase N/A · 2 location(s) · First Affiliated Hospital Xi'an Jiaotong University · NCT07079150High vs. Standard Dose Influenza Vaccines in Lung Transplant (Repeater)
Phase 2 · 1 location(s) · Vanderbilt University Medical Center · NCT07192458Nosocomial Pneumonia After Coronary Artery Bypass Grafting
Phase N/A · 1 location(s) · Tomsk National Research Medical Center of the Russian Academ · NCT07476274Evaluation of the Quality of Life Induced by the Cinnamon Anti-odor Dressing in Patients With Malodorous Wounds
NA · 7 location(s) · Assistance Publique - Hôpitaux de Paris · NCT05685628Study of AHB-171 in Chronic Hepatitis B Participants
Phase 2 · 10 location(s) · Ausper Biopharma Co., Ltd. · NCT07630727Assessment of Infection Activity in Travelers and Migrants Diagnosed With Chronic Schistosomiasis
NA · 8 location(s) · IRCCS Sacro Cuore Don Calabria di Negrar · NCT06873308Effect of a Multi-strain Probiotic on Recurrent Vulvovaginal Candidiasis
NA · 6 location(s) · The Archer-Daniels-Midland Company · NCT06480604Evaluation of the Efficacy of Azithromycin in Idiopathic Purulent Oedematous Sinusitis in Adults
Phase 3 · 13 location(s) · Centre Hospitalier Intercommunal Creteil · NCT05157685Safety and Effectiveness of a Remdesivir Treatment to Prevent Severe COVID-19 in Kidney Transplant Patients
Phase 2 · 1 location(s) · Fundación FLS de Lucha Contra el Sida, las Enfermedades Infe · NCT07197164Clinical Utility of Portable Dynamic Chest X Ray (DDR) in the ICU
NA · 1 location(s) · Brigham and Women's Hospital · NCT06538376Cardiovascular Risk in Children With Chronic Conditions Study
Phase N/A · 3 location(s) · Semmelweis University · NCT07086989Breakthrough CMV Lung Transplant -Multicentre
Phase N/A · 1 location(s) · University of Alberta · NCT04439916COVID-19 Booster and IIV Schedule in Immunocompromised Hosts
Phase 2 · 3 location(s) · McGill University Health Centre/Research Institute of the Mc · NCT06599658Inspiratory Work of Breathing Before and After Extubation
Phase N/A · 1 location(s) · University Health Network, Toronto · NCT07017608Early Detection of Infectious and Noninfectious Lung Diseases Following Allogeneic Hematopoietic Stem Cell Transplantati
Phase N/A · 1 location(s) · National Heart, Lung, and Blood Institute (NHLBI) · NCT06093867CytOSorb TreatMent Of Critically Ill PatientS Registry
Phase N/A · 28 location(s) · CytoSorbents, Inc · NCT05146336Prevalence and Outcome of SARS-CoV-2 Infection & COVID-19 in Transplant Recipients: The COVITRA Study
Phase N/A · 1 location(s) · Universitaire Ziekenhuizen KU Leuven · NCT04579471Combined Light, ExVivo, and Antivirals for Recipients of Lungs From HBV Donors
Phase 4 · 1 location(s) · University Health Network, Toronto · NCT07189377Evaluation of Patients With Immune Function Abnormalities
Phase N/A · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT00128973Evolution of Respiratory Function in Lung Transplant Patients With Moderate to Severe Covid-19 Infection
Phase N/A · 1 location(s) · University Hospital, Strasbourg, France · NCT06490744
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.